These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 26685215

  • 1. Cyclin A2 and CDK2 as Novel Targets of Aspirin and Salicylic Acid: A Potential Role in Cancer Prevention.
    Dachineni R, Ai G, Kumar DR, Sadhu SS, Tummala H, Bhat GJ.
    Mol Cancer Res; 2016 Mar; 14(3):241-52. PubMed ID: 26685215
    [Abstract] [Full Text] [Related]

  • 2. Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer.
    Dachineni R, Kumar DR, Callegari E, Kesharwani SS, Sankaranarayanan R, Seefeldt T, Tummala H, Bhat GJ.
    Int J Oncol; 2017 Dec; 51(6):1661-1673. PubMed ID: 29075787
    [Abstract] [Full Text] [Related]

  • 3. Aspirin and salicylic acid decrease c-Myc expression in cancer cells: a potential role in chemoprevention.
    Ai G, Dachineni R, Muley P, Tummala H, Bhat GJ.
    Tumour Biol; 2016 Feb; 37(2):1727-38. PubMed ID: 26314861
    [Abstract] [Full Text] [Related]

  • 4. 6-Methoxyflavone induces S-phase arrest through the CCNA2/CDK2/p21CIP1 signaling pathway in HeLa cells.
    Zhang C, Quan Y, Yang L, Bai Y, Yang Y.
    Bioengineered; 2022 Mar; 13(3):7277-7292. PubMed ID: 35246013
    [Abstract] [Full Text] [Related]

  • 5. Loss of Cdk2 and cyclin A2 impairs cell proliferation and tumorigenesis.
    Gopinathan L, Tan SL, Padmakumar VC, Coppola V, Tessarollo L, Kaldis P.
    Cancer Res; 2014 Jul 15; 74(14):3870-9. PubMed ID: 24802190
    [Abstract] [Full Text] [Related]

  • 6. Identification of Novel Cyclin A2 Binding Site and Nanomolar Inhibitors of Cyclin A2-CDK2 Complex.
    Kim SS, Alves MJ, Gygli P, Otero J, Lindert S.
    Curr Comput Aided Drug Des; 2021 Jul 15; 17(1):57-68. PubMed ID: 31889491
    [Abstract] [Full Text] [Related]

  • 7. Induction of cell cycle arrest via the p21, p27-cyclin E,A/Cdk2 pathway in SMMC-7721 hepatoma cells by clioquinol.
    Huang Z, Wang L, Chen L, Zhang Y, Shi P.
    Acta Pharm; 2015 Dec 15; 65(4):463-71. PubMed ID: 26677902
    [Abstract] [Full Text] [Related]

  • 8. Avian reovirus p17 and σA act cooperatively to downregulate Akt by suppressing mTORC2 and CDK2/cyclin A2 and upregulating proteasome PSMB6.
    Huang WR, Chi PI, Chiu HC, Hsu JL, Nielsen BL, Liao TL, Liu HJ.
    Sci Rep; 2017 Jul 12; 7(1):5226. PubMed ID: 28701787
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of human cytomegalovirus immediate-early gene expression by cyclin A2-dependent kinase activity.
    Oduro JD, Uecker R, Hagemeier C, Wiebusch L.
    J Virol; 2012 Sep 12; 86(17):9369-83. PubMed ID: 22718829
    [Abstract] [Full Text] [Related]

  • 10. Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA/PLK1 pathway.
    Li Z, Zhang Y, Zhou Y, Wang F, Yin C, Ding L, Zhang S.
    Sci Rep; 2021 Dec 08; 11(1):23681. PubMed ID: 34880385
    [Abstract] [Full Text] [Related]

  • 11. NPTX1 inhibits colon cancer cell proliferation through down-regulating cyclin A2 and CDK2 expression.
    Peng X, Pan K, Zhao W, Zhang J, Yuan S, Wen X, Zhou W, Yu Z.
    Cell Biol Int; 2018 May 08; 42(5):589-597. PubMed ID: 29345391
    [Abstract] [Full Text] [Related]

  • 12. Curcumin suppresses proliferation of colon cancer cells by targeting CDK2.
    Lim TG, Lee SY, Huang Z, Lim DY, Chen H, Jung SK, Bode AM, Lee KW, Dong Z.
    Cancer Prev Res (Phila); 2014 Apr 08; 7(4):466-74. PubMed ID: 24550143
    [Abstract] [Full Text] [Related]

  • 13. Cyclin A2 and its associated kinase activity are required for optimal induction of progesterone receptor target genes in breast cancer cells.
    Moore NL, Edwards DP, Weigel NL.
    J Steroid Biochem Mol Biol; 2014 Oct 08; 144 Pt B(0 0):471-82. PubMed ID: 25220500
    [Abstract] [Full Text] [Related]

  • 14. A novel arylbenzofuran induces cervical cancer cell apoptosis and G1/S arrest through ERK-mediated Cdk2/cyclin-A signaling pathway.
    Ming P, Cai T, Li J, Ning Y, Xie S, Tao T, Tang F.
    Oncotarget; 2016 Jul 05; 7(27):41843-41856. PubMed ID: 27259234
    [Abstract] [Full Text] [Related]

  • 15. Cymbopogon proximus phytochemicals induce S-phase arrest in A549 lung cancer cell lines via CDK2/cyclin A2 inhibition: gas chromatography-mass spectrometry and molecular docking analyses.
    Seif-Eldein NA, Abu El Wafa SA, Mohammed EZ, Temraz A.
    Z Naturforsch C J Biosci; 2024 Sep 25; 79(9-10):275-284. PubMed ID: 38780470
    [Abstract] [Full Text] [Related]

  • 16. Aspirin metabolites 2,3‑DHBA and 2,5‑DHBA inhibit cancer cell growth: Implications in colorectal cancer prevention.
    Sankaranarayanan R, Valiveti CK, Dachineni R, Kumar DR, Lick T, Bhat GJ.
    Mol Med Rep; 2020 Jan 25; 21(1):20-34. PubMed ID: 31746356
    [Abstract] [Full Text] [Related]

  • 17. Combinatorial chemoprevention reveals a novel smoothened-independent role of GLI1 in esophageal carcinogenesis.
    Ilyas SI, Demars CJ, Comba A, Gainullin VG, Rizvi Z, Almada LL, Wang K, Lomberk G, Fernández-Zapico ME, Buttar NS.
    Cancer Res; 2010 Sep 01; 70(17):6787-96. PubMed ID: 20647328
    [Abstract] [Full Text] [Related]

  • 18. A new arylbenzofuran derivative functions as an anti-tumour agent by inducing DNA damage and inhibiting PARP activity.
    Chen H, Zeng X, Gao C, Ming P, Zhang J, Guo C, Zhou L, Lu Y, Wang L, Huang L, He X, Mei L.
    Sci Rep; 2015 Jun 04; 5():10893. PubMed ID: 26041102
    [Abstract] [Full Text] [Related]

  • 19. The effect of miR-381 on proliferation and prognosis of breast cancer by altering CCNA2 expression.
    Cao MG, Wang Y, Yang ZM, Wang Y, Wang MQ, Zhuo S, Yang Y, Liu CS.
    J Obstet Gynaecol; 2024 Dec 04; 44(1):2360547. PubMed ID: 38904638
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of Benzamide-Chalcone Derivatives as EGFR/CDK2 Inhibitor: Synthesis, In-Vitro Inhibition, and Molecular Modeling Studies.
    Joshi A, Bhojwani H, Wagal O, Begwani K, Joshi U, Sathaye S, Kanchan D.
    Anticancer Agents Med Chem; 2022 Dec 04; 22(2):328-343. PubMed ID: 33858315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.